Therefore, IGF-1 was found to be significantly elevated in both SZ and MDD patients in comparison to controls as was predicted to be a mechanism to compensate for central reduced neuroplasticity and myelination in both PDs. The gene discussed is IGF1; the disease is major depressive disorder.